Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.
Multiple drug class combinations are often prescribed for the treatment of schizophrenia, although antipsychotic monotherapy reflects FDA labeling and scientific justification for combinations is highly variable. This study was performed to gain current data regarding drug treatment of schizophrenia as practiced in the community and to assess the frequencies of off-label drug class combinations. 200 DSM IV-diagnosed schizophrenic patients recruited from community treatment sources participated in this cross-sectional study of community based schizophrenic patients. Drug class categories include First and Second Generation Antipsychotic drugs (FGA and SGA, respectively), mood stabilizers, antidepressants and anti-anxiety drugs. 25.5% of patients received antipsychotic monotherapy; 70% of patients received an antipsychotic and another drug class. A total of 42.5% of patients received more than one antipsychotic drug. The most common drug class combination was antipsychotic and a mood stabilizer. Stepwise linear discriminant function analysis identified the diagnosis of schizoaffective schizophrenia, history of having physically hurt someone and high scores on the General Portion of the PANSS rating scale predicted the combined use of an antipsychotic drug and a mood stabilizer. "Real world" pharmacotherapy of schizophrenia has developed its own established practice that is predominantly off-label and may have outstripped current data support. The economic implications for public sector payers are substantial as well as for the revenue of the pharmaceutical industry, whose promotion of off-label drug use is an increasingly problematic. These data are consistent with the recognition of the therapeutic limitations of both first and second generation antipsychotic drugs.
Pickar
David
D
Gabriel Sciences, LLC, Cabin John, Maryland, USA. dpickar@gabrielpharma.com
Vinik
Jessie
J
Bartko
John J
JJ
D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology*; D004334:Drug Administration Schedule; D004348:Drug Labeling; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D011570:Psychiatry / Q000379:methods; D012107:Research Design; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents
Am J Psychiatry. 2002 Jun;159(6):1035-43
12042194
N Engl J Med. 2005 Sep 22;353(12):1209-23
16172203
Psychiatr Serv. 2006 Aug;57(8):1093
16870958
Arch Gen Psychiatry. 2003 Jun;60(6):553-64
12796218
Lancet. 1995 Mar 4;345(8949):557-62
7539875
Am J Psychiatry. 2000 Sep;157(9):1379-89
10964850
N Engl J Med. 2008 Apr 3;358(14):1427-9
18385495
Am J Psychiatry. 2004 Apr;161(4):700-6
15056517
Psychiatr Serv. 2003 Jan;54(1):55-9
12509667
J Clin Psychiatry. 2003 Jun;64(6):673-9
12823082
Ann Intern Med. 2006 Aug 15;145(4):284-93
16908919
Am J Psychiatry. 1999 Aug;156(8):1138-48
10450252
Am J Psychiatry. 2007 Mar;164(3):428-36
17329467
Schizophr Res. 2006 May;84(1):90-9
16631354
Am J Psychiatry. 1991 Jun;148(6):714-26
1674645
Schizophr Bull. 2002;28(1):75-84
12047024
Neuropsychopharmacology. 2003 Jan;28(1):182-92
12496955
Arch Gen Psychiatry. 2006 Oct;63(10):1074-6
17015809
J Clin Psychiatry. 2004 May;65(5):679-85
15163255
JAMA. 2008 Apr 16;299(15):1759-61
18413865
Can J Psychiatry. 2001 May;46(4):334-9
11387789
Schizophr Res. 2007 Jan;89(1-3):91-100
17070017
FDA Consum. 2004 Jul-Aug;38(4):36-7
15346583
Br J Psychiatry. 1979 Apr;134:382-9
444788
Schizophr Bull. 1987;13(2):261-76
3616518
J Clin Psychopharmacol. 2000 Jun;20(3):357-61
10831024
Arch Gen Psychiatry. 2006 Oct;63(10):1069-72
17015808
J Clin Psychiatry. 2006 Aug;67(8):1261-5
16965205
Arch Gen Psychiatry. 2006 Oct;63(10):1079-87
17015810
Int Clin Psychopharmacol. 2006 Nov;21(6):355-62
17012982
JAMA. 2008 Apr 23;299(16):1949-51
18430914
Ann Intern Med. 2006 Aug 15;145(4):305-7
16908923
Pharmacotherapy. 2006 Mar;26(3):323-32
16503712
Psychiatr Serv. 2006 Aug;57(8):1094-101
16870959
Arch Intern Med. 2006 May 8;166(9):1021-6
16682577
J Clin Psychiatry. 1999 Jul;60(7):425-6
10453794
Psychiatr Serv. 2006 Jan;57(1):21-3
16399958